GESTIÓN EN SALUD PÚBLICA: Training Course: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens | FDA

miércoles, 18 de diciembre de 2019

Training Course: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens | FDA

Training Course: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens | FDA

FDA Medical Countermeasures Initiative Update

FDA Medical Countermeasures Initiative Update

pcoming courses: Save the dates. Achieving Data Quality and Integrity in Maximum Containment Laboratories, April 20-24, 2020, Bethesda, Maryland (reg. opens Jan. 6, 2020). Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens, July 27-31, 2020, Omaha, Nebraska (reg. opens April 6, 2020). Attendance is free, but seating is limited.

Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens

July 27-31, 2020, Omaha, Nebraska

National Ebola Training and Education Center (NETEC)

Registration opens April 6, 2020, and closes when the course is full

Attendees will learn to apply best practices for clinical trials during an outbreak involving high-consequence pathogens, and recognize and prevent potential risks to data quality and integrity. Professionals who have experience with high-consequence pathogen clinical trials are encouraged to apply to attend.

Learn more about this course

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)